Literature DB >> 19406319

Nanotechnology in urology.

Shihua Jin1, Vinod Labhasetwar.   

Abstract

Nanomedicine is a new distinct scientific discipline that explores applications of nanoscale materials for various biomedical applications. Translational nanomedicine is undergoing rapid transition from development and evaluation in laboratory animals to clinical practices. In the future, it is anticipated that nanotechnology can provide urologists a new point of view to understand the mechanism of disease, tools for early diagnosis of the disease, and effective modality for treatment. This article summarizes some of the emerging applications of nanomedicine in urology.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19406319      PMCID： PMC2676239          DOI： 10.1016/j.ucl.2009.02.005

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN： 0094-0143            Impact factor:   2.241


  58 in total

1.  Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer.

Authors:  Sanjeeb K Sahoo; Wenxue Ma; Vinod Labhasetwar
Journal:  Int J Cancer       Date:  2004-11-01       Impact factor: 7.396

2.  Methylprednisolone in bilayer liposomes prolongs cardiac and renal allograft survival, inhibits macrophage activation, and selectively modifies antigen presentation and T-helper cell function in rat recipients.

Authors:  J Binder; R Braeutigam; A Oertl; W Kramer; D Jonas; W W Hancock; J W Kupiec-Weglinski
Journal:  Transplant Proc       Date:  1998-06       Impact factor: 1.066

3.  Quantum dot bioconjugates for ultrasensitive nonisotopic detection.

Authors:  W C Chan; S Nie
Journal:  Science       Date:  1998-09-25       Impact factor: 47.728

4.  Gene therapy -- promises, problems and prospects.

Authors:  I M Verma; N Somia
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

5.  Comparison of intraurethral liposomal and intracavernosal prostaglandin-E1 in the management of erectile dysfunction.

Authors:  P F Engelhardt; E Plas; W A Hübner; H Pflüger
Journal:  Br J Urol       Date:  1998-03

6.  In vivo cancer targeting and imaging with semiconductor quantum dots.

Authors:  Xiaohu Gao; Yuanyuan Cui; Richard M Levenson; Leland W K Chung; Shuming Nie
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

7.  Prospective randomized Phase II trial of pegylated doxorubicin in the management of symptomatic hormone-refractory prostate carcinoma.

Authors:  Axel Heidenreich; Frank Sommer; Carsten H Ohlmann; Andres J Schrader; Peter Olbert; Joachim Goecke; Udo H Engelmann
Journal:  Cancer       Date:  2004-09-01       Impact factor: 6.860

8.  Liposome encapsulated prostaglandin E1 in erectile dysfunction: correlation between in vitro delivery through foreskin and efficacy in patients.

Authors:  M Foldvari; C Oguejiofor; S Afridi; T Kudel; T Wilson
Journal:  Urology       Date:  1998-11       Impact factor: 2.649

9.  Improving the signal sensitivity and photostability of DNA hybridizations on microarrays by using dye-doped core-shell silica nanoparticles.

Authors:  Xichun Zhou; Jizhong Zhou
Journal:  Anal Chem       Date:  2004-09-15       Impact factor: 6.986

10.  Magnetic nanoparticles with dual functional properties: drug delivery and magnetic resonance imaging.

Authors:  Tapan K Jain; John Richey; Michelle Strand; Diandra L Leslie-Pelecky; Chris A Flask; Vinod Labhasetwar
Journal:  Biomaterials       Date:  2008-07-22       Impact factor: 12.479
View more
  2 in total

Review 1.  Urological technology: where will we be in 20 years' time?

Authors:  Darryl Ethan Bernstein; Brett Sydney Bernstein
Journal:  Ther Adv Urol       Date:  2018-06-17

2.  Urovision 2020: The future of urology.

Authors:  Vivek Venkatramani
Journal:  Indian J Urol       Date:  2015 Apr-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.